623 related articles for article (PubMed ID: 26887816)
1. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
[TBL] [Abstract][Full Text] [Related]
2. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
[TBL] [Abstract][Full Text] [Related]
3. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
Rühlemann M; Liwinski T; Heinsen FA; Bang C; Zenouzi R; Kummen M; Thingholm L; Tempel M; Lieb W; Karlsen T; Lohse A; Hov J; Denk G; Lammert F; Krawczyk M; Schramm C; Franke A
Aliment Pharmacol Ther; 2019 Sep; 50(5):580-589. PubMed ID: 31250469
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis.
Cortez RV; Moreira LN; Padilha M; Bibas MD; Toma RK; Porta G; Taddei CR
Front Immunol; 2020; 11():598152. PubMed ID: 33613519
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.
Kevans D; Tyler AD; Holm K; Jørgensen KK; Vatn MH; Karlsen TH; Kaplan GG; Eksteen B; Gevers D; Hov JR; Silverberg MS
J Crohns Colitis; 2016 Mar; 10(3):330-7. PubMed ID: 26526357
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
Del Chierico F; Cardile S; Baldelli V; Alterio T; Reddel S; Bramuzzo M; Knafelz D; Lega S; Bracci F; Torre G; Maggiore G; Putignani L
Inflamm Bowel Dis; 2024 Apr; 30(4):529-537. PubMed ID: 37696680
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker.
Iwasawa K; Suda W; Tsunoda T; Oikawa-Kawamoto M; Umetsu S; Takayasu L; Inui A; Fujisawa T; Morita H; Sogo T; Hattori M
Sci Rep; 2018 Apr; 8(1):5480. PubMed ID: 29615776
[TBL] [Abstract][Full Text] [Related]
10. The features of mucosa-associated microbiota in primary sclerosing cholangitis.
Torres J; Bao X; Goel A; Colombel JF; Pekow J; Jabri B; Williams KM; Castillo A; Odin JA; Meckel K; Fasihuddin F; Peter I; Itzkowitz S; Hu J
Aliment Pharmacol Ther; 2016 Apr; 43(7):790-801. PubMed ID: 26857969
[TBL] [Abstract][Full Text] [Related]
11. The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II.
Rossen NG; Fuentes S; Boonstra K; D'Haens GR; Heilig HG; Zoetendal EG; de Vos WM; Ponsioen CY
J Crohns Colitis; 2015 Apr; 9(4):342-8. PubMed ID: 25547975
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
14. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
[TBL] [Abstract][Full Text] [Related]
15. Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
Gwela A; Siddhanathi P; Chapman RW; Travis S; Powrie F; Arancibia-Cárcamo CV; Geremia A
J Crohns Colitis; 2017 Sep; 11(9):1124-1134. PubMed ID: 28383652
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.
Lapidot Y; Amir A; Ben-Simon S; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Ben-Ari Z; Safran M
Hepatol Int; 2021 Feb; 15(1):191-201. PubMed ID: 32949377
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis.
de Krijger M; Hageman IL; Li Yim AYF; Verhoeff J; Garcia Vallejo JJ; van Hamersveld PHP; Levin E; Hakvoort TBM; Wildenberg ME; Henneman P; Ponsioen CY; de Jonge WJ
Front Immunol; 2022; 13():840935. PubMed ID: 35371111
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
[TBL] [Abstract][Full Text] [Related]
19. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
[TBL] [Abstract][Full Text] [Related]
20. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
Liu Q; Li B; Li Y; Wei Y; Huang B; Liang J; You Z; Li Y; Qian Q; Wang R; Zhang J; Chen R; Lyu Z; Chen Y; Shi M; Xiao X; Wang Q; Miao Q; Fang JY; Gershwin ME; Lian M; Ma X; Tang R
Gut; 2022 May; 71(5):899-909. PubMed ID: 34035120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
